Stock Taper 
DMAAU
$10.82
▲ UP 0.28% (0.03)
KEY STATISTICS
Market Cap$355.52 M
52w High$12.50
52w Low$10.30
Dividend Yield—
Frequency—
P/E—
Volume9
Shares Out.23.43M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Roger Bendelac
ABOUT
SECTOR
Financial Services
WENT PUBLIC
January 27, 2025
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
2
PRICE
$10.82 ▲ UP 0.28% (+$0.03)About Drugs Made In America Acquisition Corp. Units
https://dmaacorp.com ↗Drugs Made In America Acquisition Corp. is a SPAC founded in May 2024 in Fort Lauderdale, Florida, aiming to complete a business combination through merger, asset acquisition, share exchange, or restructuring.
INDUSTRY
Shell Companies
A SERVICE DRUGS MADE IN AMERICA ACQUISITION CORP. UNITS IS KNOWN FOR
Special Purpose Acquisition Company (SPAC) Units
Drugs Made In America Acquisition Corp. is a SPAC that raises capital through an IPO to acquire or merge with a private company, with no commercial operations or products of its own.
RATINGS SNAPSHOT
Overall rating: C-
Discounted Cash Flow1
Return On Equity1
Return On Assets4
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 POLE | $10.72 | COMPARE |
 FACT | $10.71 | COMPARE |
 HVII | $10.00 | COMPARE |
 PLMK | $10.71 | COMPARE |
 PMTR | $10.41 | COMPARE |
 RAC | $10.58 | COMPARE |
 SZZL | $10.47 | COMPARE |
 DRDB | $10.68 | COMPARE |